ANI Pharmaceuticals Inc (ANIP)

Return on assets (ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net income	US$ in thousands	18,779	-47,896	-42,603	-22,548	6,094
Total assets	US$ in thousands	904,422	760,087	771,598	461,190	456,789
ROA		2.08%	-6.30%	-5.52%	-4.89%	1.33%

December 31, 2023 calculation

ROA = Net income ÷ Total assets
= $18,779K ÷ $904,422K
= 2.08%

ANI Pharmaceuticals Inc's return on assets (ROA) has seen fluctuations over the past five years. In 2019, the ROA was at a positive 1.31%, indicating that the company generated a modest return on its assets. However, in the subsequent years, the ROA turned negative, signifying that the company's assets were not effectively utilized to generate profits. The most significant improvement was observed in 2023, with an ROA of 1.90%, indicating a return to positive territory and a better utilization of assets to generate profits compared to the previous years.

Overall, ANI Pharmaceuticals Inc's ROA has been volatile, and investors and stakeholders may want to monitor future performance to ensure sustained profitability and efficient asset utilization.